Impact of antiepileptic-drug treatment burden on health-care-resource utilization and costs
Krithika Rajagopalan,1 Sean D Candrilli,2 Mayank Ajmera2 1Sunovion Pharmaceuticals Inc, Marlborough, MA 01752, USA; 2RTI Health Solutions, Research Triangle Park, NC 27709, USA Background: Complex titration requirements and dosing of antiepileptic drugs (AEDs) may pose a significant treatment burden...
Main Authors: | Rajagopalan K, Candrilli SD, Ajmera M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/impact-of-antiepileptic-drug-treatment-burden-on-health-care-resource--peer-reviewed-article-CEOR |
Similar Items
-
Drug utilization study of antiepileptic drugs in the pediatric department, tertiary care hospital, Bangalore, India
by: Zahra Khoshdel, et al.
Published: (2022-01-01) -
Evaluation of the direct costs of epilepsy in a sample of Egyptian patients following up in Ain Shams University Hospital
by: Salem Abdelhady, et al.
Published: (2020-11-01) -
NEW BIOMOLECULAR TARGETS FOR ANTIEPILEPTIC DRUGS
by: T. A. Voronina, et al.
Published: (2016-05-01) -
Epilepsy, Pregnancy, and Antiepileptic Drugs
by: Betül TEKİN
Published: (2018-01-01) -
Epilepsy, Antiepileptic Drugs and Lipid Mechanisms
by: Özden KAMIŞLI, et al.
Published: (2018-01-01)